Leah R. Neufeld - 31 Oct 2022 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
CHIEF PEOPLE OFFICER
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Leah R. Neufeld
Issuer symbol
IMRX
Transactions as of
31 Oct 2022
Net transactions value
$0
Form type
4
Filing time
02 Nov 2022, 09:03:28 UTC
Previous filing
20 Oct 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +88,600 $0.000000 88,600 31 Oct 2022 Class A Common Stock 88,600 $13.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying shares on October 17, 2023 and then in equal monthly installments over the subsequent three years, subject to Ms. Neufeld's continued employment through each applicable vesting date.